Redesigning the Clinical Effectiveness Research Paradigm Innovation and Practice-Based Approaches: Workshop Summary (2010) / Chapter Skim
Currently Skimming:
Appendix B: Biographical Sketches of Workshop Participants
Appendix B: Biographical Sketches of Workshop Participants
Pages 387-408
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 387... ...
He is Associate Clinical Professor of Medicine at the UCSF Institute for Health Policy Studies, where he works on the California Health Benefits Review Program, an assessment program for proposed health plan mandates for the California legislature. Previously, he was Senior Advisor for the Health Technology Center (HealthTech)
|
From page 388... ...
His research on health disparities, variations in healthcare quality, and lung cancer epidemiology has appeared in The New England Journal of Medicine, the Journal of the American Medical Association, and the Journal of the National Cancer Institute. Bach served as a senior adviser to the Administrator of the Centers for Medicare & Medicaid Services from February 2005 through November 2006, where his work focused on improving evidence about the effect of therapies and devices and revising payment to enhance care quality.
|
From page 389... ...
Dr. Berry is a statistics editor for the Journal of the National Cancer Institute and associate editor for Breast Cancer Research and Treatment and also for Clinical Cancer Research, and he is a Fellow of the American Statistical Association and of the Institute of Mathematical Statistics.
|
From page 390... ...
efforts for many of the best-known clinical trials in cardiovascular disease. With his colleagues from the Duke Databank for Cardiovascular Disease, he has written extensively about clinical and economic outcomes in chronic heart disease.
|
From page 391... ...
Crown, Ph.D., is President of i3 Innovus, the Health Economics and Outcomes Research division of Ingenix.
|
From page 392... ...
Firth's responsibilities are worldwide strategic medical input for the corporation and liaison with major medical societies, publishing results of Cordis' clinical research articles, and inter-company cardiovascular research and health policy activities within Johnson & Johnson. He was appointed to this position in August 2007.
|
From page 393... ...
She has been the Director of the Data Coordinating Center for the NHLBI-sponsored REMATCH trial, is the PI of the DCC for a SCCOR grant on the biology of long-term LVAD implantation, and co-PI for the NHLBI-sponsored CT Surgery Network. She co-chairs the cost-effectiveness section of the INTERMACS registry of mechanical circulatory support devices.
|
From page 394... ...
Before founding the GPPC, Hudson was the Assistant Director of the National Human Genome Research Institute (NHGRI) responsible for communications, legislation, planning, and education activities.
|
From page 395... ...
and a Deputy Director of the National Institutes of Health. He was at Stanford University for 23 years where he served as the Shelagh Galligan Professor of Pediatrics, Associate Dean for Children's Health, Associate Chair for Research, Chief of the Division of Immunology and Transplantation Biology, and Executive Director of the Children's Health Initiative.
|
From page 396... ...
A board-certified cardiologist, he received his M.D. from Albany Medical College in 1985 and underwent postgraduate training within the Harvard University system at Massachusetts General Hospital, Boston Beth Israel Hospital, and the Harvard School of Public Health.
|
From page 397... ...
She joined the National Heart, Lung, and Blood Institute in 1987 where she was heavily involved in large-scale cohort studies such as the Cardiovascular Health Study and the Framingham Heart Study. She moved to NHGRI in 2005 to lead efforts in applying genomic technologies to population research, including the Genetic Association Information Network (GAIN)
|
From page 398... ...
at Stanford University, from which he was on leave during his government service. He directed Stanford's Program on Health Outcomes Research, and he was also associate editor of the Journal of Health Economics and co-Principal Investigator of the Health and Retirement Study (HRS)
|
From page 399... ...
He is a principal investigator in the NINDS-supported ARUBA trial, an international RCT comparing watchful waiting to lesion eradication for unruptured brain arteriovenous malformations, co-Principal Investigator on an NHLBI-sponsored SCCOR grant studying mechanical circulatory support devices in advanced heart failure patients, and coPrincipal Investigator on the NHLBI-sponsored cardio-thoracic surgery network.
|
From page 400... ...
from the University of Saskatchewan, College of Medicine and completed his postdoctoral clinical training in internal medicine and gastroenterology at the University of Toronto. He is a Fellow of the American College of Physicians, a Fellow of the American College of Gastroenterology, a member of the American Association of Immunologists, and the Society for Clinical Trials.
|
From page 401... ...
Normand has developed a long line of research on methods for the analysis of patterns of treatment and quality of care for patients with cardiovascular disease and patients with mental disorders. Her work in the area of profiling medical care providers involves developing analytic methods for (1)
|
From page 402... ...
He is a member of the Association of American Medical Colleges Advisory Panel on Research and the IOM Roundtable on Evidenced-Based Medicine, and he currently chairs the FDA Drug Safety and Risk Management Advisory Committee. He has chaired the Executive Committee of the HMO Research Network, was co-chair of the Board of Scientific Counselors of the CDC's Center for Infectious Diseases, chaired the NIH study section, Epidemiology and Disease Control 2, and the CDC Office of Health Care Partnerships Steering Committee.
|
From page 403... ...
His work includes fundamental studies of psychotropic drugs and injuries, nonsteroidal anti-inflammatory drugs (NSAIDs) and upper gastrointestinal disease, NSAIDs/coxibs and the risk of coronary heart disease, and medications and sudden cardiac death.
|
From page 404... ...
He is currently Senior Vice President of clinical advancement, where he leads efforts to promote efficient and effective health care, provide tools and information to doctors and patients to promote health, and foster the growth of evidencebased medicine. From 1997 to 2003, he was Executive Vice President of the Robert Wood Johnson Foundation (RWJF)
|
From page 405... ...
Dr. Schwartz is a member of the NHLBI Adult Treatment Panel III National Cholesterol Education Program; Blue Cross and Blue Shield Associations Medical Advisory Panel; CMS Medicare Coverage Advisory Committee (MCAC)
|
From page 406... ...
His research encompasses the safety of drugs, devices, vaccines, and medical procedures. Current studies include postmarketing safety studies for recently approved drugs, natural history of disease studies to provide context for Phase III clinical trials, studies of the impact of drug labeling and warnings on prescribing behavior, and determinants of drug uptake and discontinuation.
|
From page 407... ...
He also served on the NIMH Services Research and Clinical Epidemiology Study Section. He is currently Chair of the WHO World Mental Health Study Services Research Work Group.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.